HD
47
4
TSN
35
-8
HPQ
49
5
CB
50
4
OKE
67
3
CCL
53
6
BRK.B
40
4
GPC
37
3
AMP
40
3
GRMN
53
3
FOX
46
4
INTU
63
4
ADM
24
2
ISRG
71
5
DO
37
7
CI
52
2
ZBH
59
5
AZO
55
5
CMA
48
3
DG
14
2
HD
47
4
TSN
35
-8
HPQ
49
5
CB
50
4
OKE
67
3
CCL
53
6
BRK.B
40
4
GPC
37
3
AMP
40
3
GRMN
53
3
FOX
46
4
INTU
63
4
ADM
24
2
ISRG
71
5
DO
37
7
CI
52
2
ZBH
59
5
AZO
55
5
CMA
48
3
DG
14
2
Financhill
Back

Mersana Therapeutics Quote, Financials, Valuation and Earnings

Radical change coming - do this NOW to protect yourself

Click here to learn the three steps you must take to protect your money RIGHT NOW.
Sell
4

MRSN
Mersana Therapeutics

Last Price:
1.45
Seasonality Move:
-13.32%

7 Day Trial

ALL ACCESS PASS

$ 7

Warning signs flashing again in the market

Here's my #1 indicator to try out now.

Mersana Therapeutics Price Quote

$1.45
-0.01 (-0.68%)
(Updated: August 9, 2024 at 6:55 PM ET)

Mersana Therapeutics Key Stats

Sell
4
Mersana Therapeutics (MRSN) is a Sell
Day range:
$1.42 - $1.51
52-week range:
$1.07 - $6.28
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
5.03
P/B ratio:
7.04%
Volume:
460.6K
Avg. volume:
1.2M
1-year change:
18.7%
Market cap:
$197M
Revenue:
$36.9M
EPS:
$-1.14

How Much Does Mersana Therapeutics Make?

Is Mersana Therapeutics Growing As A Company?

  • What Is Mersana Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.18%
  • What Is Mersana Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Mersana Therapeutics Stock Price Performance

What Is Mersana Therapeutics 52-Week High & Low?

Mersana Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Mersana Therapeutics?

Is Mersana Therapeutics Cash Flow Positive?

  • What Is MRSN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$172.5M
  • What Is Mersana Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $79M
  • What Is Mersana Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $45.9M

Mersana Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    MRSN return on invested capital is -169.81%
  • What Is Mersana Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -52.07%
  • What Is MRSN Return On Equity?
    ROE is a measure of profitability and is -248.57%

Mersana Therapeutics Earnings Date & Stock Price

Mersana Therapeutics Competitors

Mersana Therapeutics Dividend Yield

Data Unavailable

Mersana Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 12.97%
Revenue: 18.5% 11.54%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 6.56
Upside from Last Price: 349.01%

Major Shareholders

  • How many MRSN shares are owned by institutional investors?
    160.4M MRSN shares are owned by institutional investors
  • How many MRSN shares are owned by insiders?
    1.3M MRSN shares are owned by insiders